Pala Francesca, Notarangelo Luigi D, Lionakis Michail S
Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
J Allergy Clin Immunol. 2025 Feb;155(2):368-376. doi: 10.1016/j.jaci.2024.10.009. Epub 2024 Oct 18.
The thymus is crucial for optimal T-cell development by facilitating the generation and selection of a diverse repertoire of T cells that can recognize foreign antigens while promoting tolerance to self-antigens. A number of inborn errors of immunity causing complete or partial defects in thymic development (athymia) and/or impaired thymic function have been increasingly recognized that manifest clinically with a combination of life-threatening infections, severe multiorgan autoimmunity, and/or cardiac, craniofacial, ectodermal, and endocrine abnormalities. The introduction of newborn screening programs and the advent of thymic transplantation show promise for early detection and improving the outcomes of patients with certain thymic inborn errors of immunity. We discuss our current understanding of the genetics, immunopathogenesis, diagnosis, and treatment of inborn errors of immunity that impair thymic development and/or function.
胸腺对于T细胞的最佳发育至关重要,它通过促进生成和选择能够识别外来抗原的多样化T细胞库,同时促进对自身抗原的耐受性来实现这一点。越来越多的先天性免疫缺陷被认识到,这些缺陷会导致胸腺发育完全或部分缺陷(无胸腺症)和/或胸腺功能受损,临床上表现为危及生命的感染、严重的多器官自身免疫以及/或心脏、颅面、外胚层和内分泌异常的组合。新生儿筛查项目的引入和胸腺移植的出现为早期检测和改善某些先天性胸腺免疫缺陷患者的预后带来了希望。我们讨论了目前对损害胸腺发育和/或功能的先天性免疫缺陷的遗传学、免疫发病机制、诊断和治疗的理解。